IN-026

N/A

Report date: 2026/03/19 20:00:18

Base Information

Drug NameIN-026
Drug Alias NameIN026IN-026
ClassificationCell and gene therapy > Gene therapy > mRNACell and gene therapy > Gene therapy > LNP
Mechanisms of ActionUrate oxidases replacements
TargetsUrate oxidase
Therapy Area/IndicationsGout
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInnorna Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInnorna Co Ltd
Inactive CompaniesN/A
Active IndicationsGout
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A